Phase IB, investigator-initiated, open-label, multi-center trial of rituximab with or without methotrexate in subjects with psoriatic arthritis and psoriasis
Phase of Trial: Phase I
Latest Information Update: 26 Nov 2014
At a glance
- Drugs Rituximab (Primary) ; Methotrexate
- Indications Psoriasis; Psoriatic arthritis
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 17 Jan 2012 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 17 Jan 2012 Actual patient number is 6 according to ClinicalTrials.gov.